An update on the evaluation and management of pulmonary hypertension in scleroderma. - Wikidata - awgldk - TriplyDB

An update on the evaluation and management of pulmonary hypertension in scleroderma.

An update on the evaluation and management of pulmonary hypertension in scleroderma.

http://www.wikidata.org/entity/Q37973014

about

Multicentre randomised placebo-controlled trial of oral anticoagulation with apixaban in systemic sclerosis-related pulmonary arterial hypertension: the SPHInX study protocol Should patients with systemic sclerosis-related pulmonary arterial hypertension be anticoagulated?

P2860

Q30490484-54FDEC99-47B3-410F-8F54-C9FE68186119 Q38106167-B93E27A1-F641-4FCB-8AD2-B6AAE1FE1FFA

P2860

An update on the evaluation and management of pulmonary hypertension in scleroderma.

http://www.wikidata.org/entity/Q37973014

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

An update on the evaluation and management of pulmonary hypertension in scleroderma.

@en

An update on the evaluation and management of pulmonary hypertension in scleroderma.

@nl

type

label

An update on the evaluation and management of pulmonary hypertension in scleroderma.

@en

An update on the evaluation and management of pulmonary hypertension in scleroderma.

@nl

prefLabel

An update on the evaluation and management of pulmonary hypertension in scleroderma.

@en

An update on the evaluation and management of pulmonary hypertension in scleroderma.

@nl

P1433

Q37973014-D1779464-4902-48A0-8401-CCDE088E43C3

P1476

Q37973014-8A733785-6DFB-49AC-B4BC-33E8A08CC7AC

P2093

Q37973014-157DD1AD-F3D5-4BB2-A4B4-67391B98D66E

P2860

Q37973014-02D06F22-73DD-4B2F-A230-85DA8929B28A

Q37973014-0CE21611-57EC-4AA1-9AA6-6E8B781364E3

Q37973014-10ED5E45-D7F0-44DD-A390-118E397F9269

Q37973014-16AEDCB1-39FD-48F0-B82B-F2400B5B57A6

Q37973014-2F2F83A3-167B-42E5-B602-51F1D4749DAF

Q37973014-3A7C7C0D-4A1B-4B2C-B4A0-4D21B6638AEF

Q37973014-3F8116DA-C2EF-47E7-812F-7D29D0235B42

Q37973014-4DCAC5AC-AEB4-4265-BED9-01EAC59862F7

Q37973014-52AE32C1-D380-4A23-B847-542FA07BC0BD

Q37973014-54E96CA2-A78A-4302-A28C-DD4881ECA6B6

P2888

Q37973014-142F2CD8-D486-4204-9B7D-DE3245675360

P304

Q37973014-1A12D0CC-894D-44BD-8295-616DC0940451

P31

Q37973014-C7D86FC8-C72A-4056-87B7-E10310D8A0C8

P356

Q37973014-2C870598-0271-4BDD-9A28-4F6670239C42

P433

Q37973014-84A6E84B-18A5-4FA3-8AC5-ACD2CC42596E

P478

Q37973014-B62DB6AB-4475-4EA7-A45E-D852B87DF956

P50

Q37973014-88F5C909-A7DF-4669-B2D7-8C7C9725F171

P577

Q37973014-A59FEB07-E93C-45A4-8FAF-882220F5EBE9

P698

Q37973014-E92FC05F-D95B-4C1F-B14F-F5C04965015D

P356

S11926-011-0226-2

P1433

Current Rheumatology Reports

P1476

An update on the evaluation and management of pulmonary hypertension in scleroderma

@en

P2093

Benjamin Schreiber

http://www.w3.org/2001/XMLSchema#string

P2860

Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease. A randomized, controlled trial

Updated clinical classification of pulmonary hypertension.

Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension: a double-blind, randomized, placebo-controlled trial.

Sildenafil citrate therapy for pulmonary arterial hypertension.

Pulsatile left ventricular assist device support as a bridge to decision in patients with end-stage heart failure complicated by pulmonary hypertension.

Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the In

Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach.

Systemic sclerosis associated pulmonary hypertension: improved survival in the current era.

Anticoagulation in pulmonary arterial hypertension: a qualitative systematic review.

Characterization of connective tissue disease-associated pulmonary arterial hypertension from REVEAL: identifying systemic sclerosis as a unique phenotype.

P2888

s11926-011-0226-2

P304

1-10

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11926-011-0226-2

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P50

P577

2012-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22215445

http://www.w3.org/2001/XMLSchema#string